Unisec

Publications

2015

Mohn KG, Cox RJ, Tunheim G, Berdal JE, Hauge AG, Jul-Larsen Å,  Peters B, Oftung F, Jonassen CM, Mjaaland S. Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway. Mohn KG, Cox RJ, Tunheim G, Berdal JE, Hauge AG, Jul-Larsen Å, Norwegian Pandemic Group, Peters B, Oftung F, Jonassen CM, Mjaaland S. PLoS One Nov. 25 10(11) 10.1371, 2015.
Abstract

2016

Savic M, Dembinski JL, Kim Y, Tunheim G, Cox RJ, Oftung F, Peters B, Mjaaland S. Epitope specific T-cell responses against influenza A in a healthy population.  Immunology, 147:165-77, 2016.
Abstract

2016

Tomar J, Born PA, Frijlink HW, Hinrichs WL
Dry influenza vaccines: towards a stable, effective and convenient alternative to conventional parenteral influenza vaccination
Expert Rev Vaccines 2016 21:1-17
Abstract  

2016

Vaccine. 2016. Marie Borggren, Jens Nielsen, Ingrid Karlsson, Tina S. Dalgaard, Ramona Trebbien, James A. Williams, and Anders Fomsgaard
A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs
Vaccine 2016 May May 19. pii: S0264-410
Abstract 

2016

Bigaeva E, van Doorn E, Liu H, Hak E
Meta-analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability
Plos One 2016 11, 5, p. e0154757
Abstract 

2016

van Doorn E, Liu H, Huckriede A, Hak E
Safety and tolerability evaluation of the use of Montanide ISA™51 as vaccine adjuvant: A systematic review
Hum Vaccin Immunother2016 12(1):159-69
Abstract  

2015

Borggren M, Nielsen J, Bragstad K. Karlsson I, Krog JS, Williams JA, fomsgaard A. Vector optimization and needle-free intrdermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans Human Vaccines & Immunotherapeutics ISSN: 2164-5515 (Print) 2164-554X 
Abstract

2015

Sardaki J, Jankovics M, Kis Z, Skare J, Fodor K, Goncol E, Visontai I, Vajo Z, Jankovics I. Protection of Chinese painted quails (Coturnix chinensis) against a highly pathogenic H5N1 avian influenza virus strain after vaccination. Arch. Virol. Published online 15 june 2015
Abstract

2015

Sarkadi J, Jankvics M, FodorK, Kis Z, Takacs M, Visontai I, Jankovics I, Gonczol E
Corrections: High-level cellular and humoral immune responses in guinea pigs immunized intradermally with a heat-inactivated VZV vaccine.
Clin. Vaccine Immunol. 2015 May;22(5):570-7.
Abstract 

2015   

Van Doorn E, Hak E., Wilffert B. National differences in requirements for ethical and competent authority approval for a multinational vaccine trial under the EU directive 2001/20/EC. Vaccines 2015, 3, 263-292; doi:10.3390/vaccines3020263.
Abstract 

2015   

Borggren M, Nielsen J, Bragstad K, Karlsson I, Krog JS, Williams JA, Fomsgaard A. Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans. Hum Vaccin Immunother 2015, 11(7), xi-xiii.
Abstract

2015  

Sarkadi J, Jankovics M, Fodor K, Takacs M, Visontai I, Jankovics I, Gonczol E. High-level cellular and humoral immune responses in guinea pigs immunized intradermally with a heat-inactivated VZV vaccine. Clin Vaccine Immunol, 2015, March 18 (Epub ahead of print). 
Abstract

2014   

Fomsgaard A. Easy needle-free intradermal delivery and vector optimization of a broad protective polyvalent influenza-A DNA vaccine for pigs and humans. Oral presentation at ISDV 2014 DNA vaccine conference, 21-23 July 2014, San Diego, CA, U.S.
Abstract 

2014

Liu H, Robinson S, Ben-Yedidia T, Caparros-Wanderley W, Gottlieb T, Babecoff R, Schmidt E, Huckriede A, Hak E
Design of randomized, double-blind, controlled, multi-centre phase IIB trials as part of the eufunded unisec project to assess the safety, immunogenicity and clinical efficacy of cross-seasonal universal influenza vaccines with or without pandemic influenza vaccine in healthy adults
Pharmacoepidemiology and Drug SafetySpecial Issue: 2014 23 SUPPL. 1(159-
Abstract